| Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study A Arfè, L Scotti, C Varas-Lorenzo, F Nicotra, A Zambon, B Kollhorst, ... bmj 354, 2016 | 307 | 2016 |
| Trends in spontaneous adverse drug reaction reports to the French Pharmacovigilance system (1986—2001) F Thiessard, E Roux, G Miremont-Salamé, A Fourrier-Réglat, ... Drug safety 28, 731-740, 2005 | 150 | 2005 |
| Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance E Roux, F Thiessard, A Fourrier, B Begaud, P Tubert-Bitter IEEE Transactions on information technology in biomedicine 9 (4), 518-527, 2005 | 102 | 2005 |
| Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU–ADR project P Avillach, JC Dufour, G Diallo, F Salvo, M Joubert, F Thiessard, F Mougin, ... Journal of the American Medical Informatics Association 20 (3), 446-452, 2013 | 82 | 2013 |
| False discovery rate estimation for frequentist pharmacovigilance signal detection methods I Ahmed, C Dalmasso, F Haramburu, F Thiessard, P Broët, P Tubert-Bitter Biometrics 66 (1), 301-309, 2010 | 73 | 2010 |
| Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting I Ahmed, F Haramburu, A Fourrier‐Réglat, F Thiessard, C Kreft‐Jais, ... Statistics in medicine 28 (13), 1774-1792, 2009 | 71 | 2009 |
| Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France A Pariente, P Avillach, F Salvo, F Thiessard, G Miremont-Salamé, ... Drug safety 35, 855-864, 2012 | 70 | 2012 |
| The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions N Moore, F Thiessard, B Begaud Pharmacoepidemiology and drug safety 14 (4), 285-286, 2005 | 65 | 2005 |
| Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal … VE Valkhoff, PM Coloma, GMC Masclee, R Gini, F Innocenti, F Lapi, ... Journal of clinical epidemiology 67 (8), 921-931, 2014 | 62 | 2014 |
| Safety of Non-steroidal Anti-inflammatory Drugs (SOS) Project Consortium. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested … A Arfè, L Scotti, C Varas-Lorenzo, F Nicotra, A Zambon, B Kollhorst, ... Bmj 354, i4857, 2016 | 59 | 2016 |
| Risk of drug-drug interactions in out-hospital drug dispensings in France: results from the DRUG-drug interaction prevalence study L Létinier, S Cossin, Y Mansiaux, M Arnaud, F Salvo, J Bezin, F Thiessard, ... Frontiers in pharmacology 10, 265, 2019 | 53 | 2019 |
| A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France F Salvo, F Leborgne, F Thiessard, N Moore, B Bégaud, A Pariente Drug safety 36, 565-572, 2013 | 48 | 2013 |
| RAVEL: retrieval and visualization in ELectronic health records. F Thiessard, F Mougin, G Diallo, V Jouhet, S Cossin, N Garcelon, ... MIE, 194-198, 2012 | 46 | 2012 |
| Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study I Ahmed, F Thiessard, G Miremont‐Salamé, B Bégaud, P Tubert‐Bitter Clinical Pharmacology & Therapeutics 88 (4), 492-498, 2010 | 46 | 2010 |
| Prognostic factors after non‐Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine cohort, France, 1986–1997 F Thiessard, P Morlat, C Marimoutou, E Labouyrie, JM Ragnaud, ... Cancer 88 (7), 1696-1702, 2000 | 42 | 2000 |
| Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study I Ahmed, F Thiessard, G Miremont-Salame, F Haramburu, C Kreft-Jais, ... Drug safety 35, 495-506, 2012 | 39 | 2012 |
| Epidemiology of memory disorders JF Dartigues, C Fabrigoule, L Letenneur, H Amieva, F Thiessard, ... Therapie 52 (5), 503-506, 1997 | 33 | 1997 |
| Artificial intelligence in public health and epidemiology R Thiébaut, F Thiessard Yearbook of medical informatics 27 (01), 207-210, 2018 | 30 | 2018 |
| Advantages and limitations of online communities of patients for research on health products S Ravoire, M Lang, E Perrin, A Audry, P Bilbault, M Chekroun, ... Therapies 72 (1), 135-143, 2017 | 29 | 2017 |
| Artificial intelligence for surveillance in public health R Thiébaut, S Cossin Yearbook of medical informatics 28 (01), 232-234, 2019 | 28 | 2019 |
